» Authors » Michael Hust

Michael Hust

Explore the profile of Michael Hust including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 160
Citations 3086
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Baatz F, Ghosh A, Herbst J, Polten S, Meyer J, Rhiel M, et al.
Mol Ther . 2025 Feb; PMID: 39955618
Chimeric antigen receptor (CAR)-induced suppression of the transcription factor B cell CLL/lymphoma 11B (BCL11B) propagates CAR-induced killer (CARiK) cell development from lymphoid progenitors. Here, we show that CRISPR-Cas9-mediated Bcl11b knockout...
2.
Zuo F, Cao Y, Sun R, Wang Q, Simonelli L, Du L, et al.
J Virol . 2024 Dec; 99(1):e0174024. PMID: 39629995
No abstract available.
3.
Metzdorf K, Jacobsen H, Kim Y, Teixeira Alves L, Kulkarni U, Cokaric Brdovcak M, et al.
Front Immunol . 2024 Aug; 15:1383086. PMID: 39119342
Current vaccines against COVID-19 elicit immune responses that are overall strong but wane rapidly. As a consequence, the necessary booster shots have contributed to vaccine fatigue. Hence, vaccines that would...
4.
Ruschig M, Nerlich J, Becker M, Meier D, Polten S, Cervantes-Luevano K, et al.
Front Immunol . 2024 Jun; 15:1407398. PMID: 38933276
Poisoning by widow-spider (genus ) bites occurs worldwide. The illness, termed latrodectism, can cause severe and persistent pain and can lead to muscle rigidity, respiratory complications, and cardiac problems. It...
5.
Marcotte H, Cao Y, Zuo F, Simonelli L, Sammartino J, Pedotti M, et al.
Proc Natl Acad Sci U S A . 2024 Jan; 121(3):e2315354120. PMID: 38194459
The emergence of Omicron lineages and descendent subvariants continues to present a severe threat to the effectiveness of vaccines and therapeutic antibodies. We have previously suggested that an insufficient mucosal...
6.
Zuo F, Cao Y, Sun R, Yisimayi A, Du L, Bertoglio F, et al.
Lancet Infect Dis . 2023 Dec; 24(1):e7-e9. PMID: 38071989
No abstract available.
7.
Abassi L, Bertoglio F, Macak Safranko Z, Schirrmann T, Greweling-Pils M, Seifert O, et al.
Viruses . 2023 Nov; 15(11). PMID: 38005829
As of now, the COVID-19 pandemic has spread to over 770 million confirmed cases and caused approximately 7 million deaths. While several vaccines and monoclonal antibodies (mAb) have been developed...
8.
Lutz S, Klausz K, Albici A, Ebinger L, Sellmer L, Teipel H, et al.
Front Immunol . 2023 Nov; 14:1227572. PMID: 37965326
The activating receptor natural killer group 2, member D (NKG2D) represents an attractive target for immunotherapy as it exerts a crucial role in cancer immunosurveillance by regulating the activity of...
9.
Dragon A, Beermann L, Umland M, Bonifacius A, Malinconico C, Ruhl L, et al.
Front Immunol . 2023 Nov; 14:1219165. PMID: 37915564
Introduction: Chimeric antigen receptor-engineered T cells (CAR-Ts) are investigated in various clinical trials for the treatment of cancer entities beyond hematologic malignancies. A major hurdle is the identification of a...
10.
Bertoglio F, Ko Y, Thomas S, Giordano L, Scommegna F, Meier D, et al.
Front Immunol . 2023 Oct; 14:1221108. PMID: 37828992
pathology is caused by a plethora of virulence factors able to combat multiple host defence mechanisms. Fibrinogen (Fg), a critical component in the host coagulation cascade, plays an important role...